Erasca (ERAS) Assets Average (2021 - 2026)
Erasca (ERAS) posted Assets Average of $428.7 million for Q1 2026, up 5.0% on a QoQ basis from $408.3 million in Q4 2025, and down 11.95% year-over-year from $486.9 million in Q1 2025.
Erasca (ERAS) Assets Average (2021 - 2026) Analysis & Trends
Erasca's Assets Average history runs 6 years deep, the most recent figure standing at $428.7 million for Q1 2026.
- Quarterly Assets Average fell 11.95% year-over-year to $428.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $428.7 million (down 11.95% YoY) and the FY2025 annual result came in at $449.3 million, changed 0.1% from the prior year.
- Assets Average was $428.7 million for Q1 2026 at Erasca, up from $408.3 million in the prior quarter.
- Across five years, Assets Average topped out at $527.3 million in Q3 2024 and bottomed at $382.7 million in Q1 2024.
- A 5-year average of $455.7 million and a median of $454.1 million in 2023 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2024 — Assets Average retreated 22.1% — and 2025, when it grew 27.24%.
- Erasca's Assets Average stood at $480.7 million in 2022, then slipped by 15.25% to $407.4 million in 2023, then climbed by 26.6% to $515.7 million in 2024, then slipped by 20.83% to $408.3 million in 2025, then gained by 5.0% to $428.7 million in 2026.
- Business Quant data shows ERAS's Assets Average at $428.7 million in Q1 2026, $408.3 million in Q4 2025, and $432.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | 428.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 428.69 Mn |
| Dec 31, 2025 | 408.28 Mn |
| Sep 30, 2025 | 432.89 Mn |
| Jun 30, 2025 | 458.32 Mn |
| Mar 31, 2025 | 486.89 Mn |
| Dec 31, 2024 | 515.71 Mn |
| Sep 30, 2024 | 527.32 Mn |
| Jun 30, 2024 | 447.88 Mn |
| Mar 31, 2024 | 382.66 Mn |
| Dec 31, 2023 | 407.35 Mn |
| Sep 30, 2023 | 430.03 Mn |
| Jun 30, 2023 | 454.10 Mn |
| Mar 31, 2023 | 491.23 Mn |
| Dec 31, 2022 | 480.67 Mn |
| Sep 30, 2022 | 445.63 Mn |
| Jun 30, 2022 | 460.15 Mn |
| Mar 31, 2022 | 488.44 Mn |
| Dec 31, 2021 | 511.68 Mn |
| Sep 30, 2021 | 366.17 Mn |